Labeled for this condition
Medicines for alzheimer's disease
7 medicines have an FDA label indicated for alzheimer's disease; 5 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for alzheimer's disease?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Memantine | none listed | 38 labelers | $0.063 per tablet 10 mg tablet | No | No current entry | 7 |
| Donepezil | Aricept | 31 labelers | $0.0484 per tablet 10 mg tablet | No | No current entry | 5 |
| Rivastigmine | Exelon | 18 labelers | $0.164 per capsule 1.5 mg capsule | No | A presentation being discontinued | 2 |
| Galantamine | none listed | 9 labelers | $0.294 per tablet 4 mg tablet | No | No current entry | 0 |
| Donepezil and memantine | Namzaric | 5 labelers | $8.44 per unit 28-10 mg | No | A presentation being discontinued | 1 |
| Lecanemab | Leqembi | none listed | n/a | Yes | No current entry | 0 |
| Donanemab | Kisunla | none listed | n/a | Yes | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price